HOME
>
臨床医学：外科
>
眼科学
> 専門医のための眼科診療クオリファイ　16　糖尿病眼合併症の新展開

専門医のための眼科診療クオリファイ　16　糖尿病眼合併症の新展開

出版社：	中山書店
著者：	大鹿哲郎大橋裕一(シリーズ総編集) 白神史雄(編)
発行日：	2013-02-26
分野：	臨床医学：外科 > 眼科学
ISBN：	9784521734743
シリーズ：	専門医のための眼科診療クオリファイ
電子書籍版：	2013-02-26 （初版第1刷）

書籍・雑誌

≪全国送料無料でお届け≫

取寄せ目安：8～14営業日

15,400 円(税込)

購入する

電子書籍

章別単位での購入はできません

ブラウザ、アプリ閲覧

15,400 円(税込)

購入する

商品紹介

網膜症をはじめ，角膜，ぶどう膜，白内障，血管新生緑内障など，糖尿病に合併する眼症状について，最新のRCT結果をもとに，抗VEGF薬，光凝固，硝子体手術を含め，これからの診療の方向性を明示する。

目次

専門医のための眼科診療クオリファイ　16
糖尿病眼合併症の新展開

―目次―

1　網膜症
2　角膜障害
3　ぶどう膜炎
4　白内障
5　血管新生緑内障
6　視神経症
7　眼科・内科連携
8　ロービジョンケア

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1 網膜症

P.2 掲載の参考文献

1 Katsuki S, et al : Recent trends in incidence of cerebral hemorrhage and infarction in Japan. A report based on death rates, autopsy case and prospective study on cerebrovascular disease. Jpn heart J 1966 ; 7 : 26-34.

2 Miyazaki M, et al : Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population : the Hisayama Study. Diabetologia 2004 ; 47 : 1411-1415.

3 Kawasaki R, et al : Impaired glucose tolerance, but not impaired fasting glucose, is associated with retinopathy in Japanese population : the Funagata study. Diabetes Obes Metab 2008 ; 10 : 646-651.

4 Harris MI, et al : Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 1997 ; 22 : 1859-1862.

P.10 掲載の参考文献

1 Cunha-Vaz JG, et al : Studies on the permeability of the blood-retinal barrier. I. On the existence, development, and site of a blood-retinal barrier. Br J Ophthalmol 1966 ; 50 : 441-453.

2 Larson DM, et al : Junctional transfer of small molecules in cultured bovine brain microvascular endothelial cells and pericytes. Microvasc Res 1987 ; 34 : 184-199.

3 Allt G, et al : cell biology and pathology. Cells Tissues Organs 2001 ; 169 : 1-11.

4 Carlson EC : Fenestrated subendothelial basement membranes in human retinal capillaries. Invest Ophthalmol Vis Sci 1989 ; 30 : 1923-1932.

5 Vinores SA, et al : Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol 1989 ; 134 : 231-235.

6 Ishibashi T, et al : Ultrastructure of retinal vessels in diabetic patients. Br J Ophthalmol 1993 ; 77 : 574-578.

7 Ishibashi T, et al : Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes 1981 ; 30 : 601-606.

P.17 掲載の参考文献

1 Davis MD, et al : Natural evolution. In : L'Esperance FA Jr, editor. Current diagnosis and management of chorio-retinal diseases. St Louis : CV Mosby ; 1977. p.179-184.

2 福田雅俊 : 糖尿病網膜症の病期分類. 堀貞夫編. 眼科MOOK 46. 糖尿病と眼科診療. 東京 : 金原出版 ; 1991. p.117-125.

3 Early Treatment Diabetic Retinopathy Study Research Group : Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991 ; 98 : 823-833.

4 Wilkinson CP, et al : Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003 ; 110 : 1677-1682.

P.24 掲載の参考文献

1 池辺徹ら : インターフェロン投与中に視力障害をきたした1例. 日本眼科紀要 1990 ; 41 : 2291-2296.

2 Guyer DR, et al : Interferon-associated retinopathy. Arch Ophthalmol 1993 ; 111 : 350-356.

3 Hayasaka S, et al : Interferon associated retinopathy. Br J Ophthalmol 1998 ; 82 : 323-325.

4 d'Alteroche L, et al : Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. J Hepatol 2006 ; 44 : 56-61.

5 Nishiwaki H, et al : Interferon alfa induces leukocyte capillary trapping in rat retinal microcirculation. Arch Ophthalmol 1996 ; 114 : 726-730.

6 Miyamoto K, et al : Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999 ; 96 : 10836-10841.

P.37 掲載の参考文献

1 Marmor MF, et al : ISCEV standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 2009 ; 118 : 69-77.

P.42 掲載の参考文献

1 The Diabetes Control and Complications Trial Research Group : The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993 ; 329 : 977-986.

2 Ohkubo Y, et al : Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study. Diabetes Res Clin Pract 1995 ; 28 : 103-117.

3 UK Prospective Diabetes Study (UKPDS) Group : Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 ; 352 : 837-853.

4 UK Prospective Diabetes Study (UKPDS) Group : Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes : UKPDS 38. BMJ 1998 ; 317 : 703-713.

5 Chaturvedi N, DIRECT Programme Study Group : Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes : randomised, placebo-controlled trials. Lancet 2008 ; 372 : 1394-1402.

6 Sjolie AK, DIRECT Programme Study Group : Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial. Lancet 2008 ; 372 : 1385-1393.

7 大規模臨床試験「FIELD」オフィシャルサイト http://fieldstudy.jp/

P.47 掲載の参考文献

1 Eremia V, et al : VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008 ; 358 : 1129-1136.

2 Kanesaki Y, et al : Vascular endothelial growth factor gene expression in correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis 2005 ; 45 : 288-294.

3 Brownlee M, et al : The pathobiology of diabetic complications : a unifying mechanism. Diabetes 2005 ; 54 : 1615-1625.

4 伊藤裕 : メタボリックドミノとは-生活習慣病の新しいとらえ方. 日本臨床 2003 ; 61 : 1837-1843.

5 Nagai N, et al : Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-κB pathway. Invest Ophthalmol Vis Sci 2007 ; 48 : 4342-4350.

6 石田晋 : 生活習慣病と抗加齢眼科学. レニン-アンジオテンシン系と炎症制御による網脈絡膜病態の是正. 日本眼科学会雑誌 2009 ; 113 : 403-423.

7 Cruickshanks KJ, et al : The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 1993 ; 100 : 862-867.

8 Wong TY, et al : Retinal microvascular abnormalities and renal dysfunction : the atherosclerosis risk in communities study. J Am Soc Nephrol 2004 ; 15 : 2469-2476.

9 田宮宗久ら : 糖尿病網膜症と糖尿病腎症との関連. 臨床眼科 1995 ; 49 : 271-275.

10 武田憲夫ら : 糖尿病網膜症と腎症の関連. 日本眼科紀要 1999 ; 50 : 759-762.

11 宮部靖子ら : 糖尿病腎症悪化による体重増減に並行して糖尿病黄斑浮腫の増減をみた症例. 日本眼科紀要 2007 ; 58 : 361-368.

12 蒔田浩司ら : 血液透析糖尿病患者の視力予後の検討. 眼科臨床医報 2002 ; 96 : 751-754.

13 山本浩司ら : 糖尿病網膜症と腎症の伸展度が一致しない症例における臨床的背景の検討. 日本眼科紀要 1996 ; 47 : 1499-1502.

P.50 掲載の参考文献

1 植木麻理ら : 硝子体手術に至った糖尿病網膜症患者背景の検討. 日本眼科紀要 2004 ; 55 : 479-482.

2 Nakamura S, et al : Tisssue kallikrein inhibits retinal neovascularization via the cleavage of vascular endothelial growth factor-165. Arterioscler Thromb Vasc Biol 2011 ; 31 : 1041-1048.

3 鈴木浩之ら : カリジノゲナーゼによる黄斑浮腫軽減効果の検討. あたらしい眼科 2011 ; 28 : 1457-1459.

4 清水弘一 : 分担研究報告書汎網膜光凝固治療による脈絡膜循環の変化と糖尿病血管新生緑内障のレーザー治療ならびに糖尿病網膜症の光凝固適応および実施基準. 平成6年度糖尿病調査研究報告書. 厚生省 : 1995. p.346-349.

5 Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy : ETDRS report number 9. Ophthalmology 1991 ; 98 : 766-785.

6 The Japanese Society of Ophthalmic Diabetology, Subcommittee on the Study of Diabetic Retinopathy Treatment : Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy. Jpn J Ophthalmol 2012 ; 56 : 52-59.

7 The Diabetic Retinopathy Study Research Group : Photocoagulation of proliferative diabetic retinopathy : relationship of adverse treatment effects to retinopathy severity : DRS Report 5. Dev Ophthalmol 1981 ; 2 : 248-261.

8 The Diabetic Retinopathy Study Research Group : Photocoagulation of proliferative diabetic retinopathy : clinical application of Diabetic Retinopathy Study findings. DRS report no.8. Ophthalmology 1977 ; 1 : 125-130.

P.54 掲載の参考文献

1 Meyer-Schwickerath G, et al : Diabetic retinopathy and photocoagulation. Am J Ophthalmol 1968 ; 66 : 597-603.

2 Diabetic Retinopathy Study Research Group : Phtotocoagulation treatment of proliferative diabetic retinopathy. The second report of diabetic retinopathy study findings. Ophthalmology 1978 ; 85 : 82-106.

3 厚生省 : 分担研究報告書汎網膜光凝固治療による脈絡膜循環の変化と糖尿病血管新生緑内障のレーザー治療ならびに糖尿病網膜症の光凝固適応および実施基準. 平成6年度糖尿病調査研究報告書. 1995. p.346-349.

4 Early Treatment Diabetic Retinopathy Study Research Group : Early photocoagulation for diabetic retinopathy : ETDRS report number 9. Ophthalmology 1991 ; 98 : 766-785.

5 Early Treatment Diabetic Retinopathy Study Research Group : Results after lens extraction in patients with diabetic retinopathy : ETDRS report number 25. Arch Ophthalmol 1999 ; 117 : 1600-1606.

6 Suto C, et al : Management of type 2 diabetes requiring panretinal photocoagulation and cataract surgery. J Cataract Refract Surg 2008 ; 34 : 1001-1006.

7 The Japanese Society Retinopathy of Ophthalmic Diabetology, Subcommittee on the Study of Diabetic Retinopathy Treatment : Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy. Jpn J Ophthalmol 2012 ; 56 : 52-59.

P.59 掲載の参考文献

1 Shimura M, et al : Quantifying alterations of macular thickness before and after pan-retinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 2003 ; 110 : 2386-2394.

2 Shimura M, et al : Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents pan-retinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision. Ophthalmology 2006 ; 113 : 381-387.

P.67 掲載の参考文献

1 Jain A, et al : Effect of pulse duration on size and character of the lesion in retinal photocoagulation. Arch Ophthalmol 2008 ; 126 : 78-85.

2 Sramek CK, et al : Therapeutic Window of Retinal Photocoagulation With Green (532-nm) and Yellow (577-nm) Lasers. Ophthalmic Surg Lasers Imaging 2012 ; 43 : 341-347.

P.70 掲載の参考文献

1 Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy : Four-year results of a randomized trial : Diabetic Retinopathy Vitrectomy Study Report 5. Arch Ophthalmol 1990 ; 108 : 958-964.

2 O'Hanley GP, et al : Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy. Ophthalmology 1985 ; 92 : 507-511.

3 Lewis H, et al : Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992 ; 99 : 753-759.

4 Sato Y, et al : Vitrectomy for diabetic macular heterotopia. Ophthalmology 1994 ; 101 : 63-67.

P.87 掲載の参考文献

1 Avery RL, et al : Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006 ; 113 : 1695-1705.

2 Aiello LP, et al : Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994 ; 331 : 1480-1487.

3 Arevalo JF, et al : Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008 ; 92 : 213-216.

4 Yamaji H, et al : Reduction in dose of intravitreous bevacizumab before vitrectomy for proliferative diabetic retinopathy. Arch Ophthalmol 2011 ; 129 : 106-107.

5 The CATT research group : Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011 ; 364 : 1897-1908.

P.90 掲載の参考文献

1 Early Treatment Diabetic Retinopathy Study Research Group : Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics : ETDRS report number 7. Ophthalmology 1991 ; 98 : 741-756.

2 Early Treatment Diabetic Retinopathy Study Research Group : Early photocoagulation for diabetic retinopathy : ETDRS report number 9. Ophthalmology 1991 ; 98 : 766-785.

3 Early Treatment Diabetic Retinopathy Study Research Group : Photocoagulation for diabetic macular edema : ETDRS report number l. Arch Ophthalmol 1985 ; 103 : 1796-1806.

4 Early Treatment Diabetic Retinopathy Study Research Group : Effects of aspirin treatment on diabetic retinopathy : ETDRS report number 8. Ophthalmology 1991 ; 98 : 757-765.

P.94 掲載の参考文献

1 Bresnick GH : Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 1983 ; 90 : 1301-1317.

2 佐藤幸裕ら : 糖尿病網膜症の黄斑病変に関する臨床的研究その2. 糖尿病網膜症に対する光凝固療法の黄斑部病変への影響. 日本眼科学会雑誌 1983 ; 87 : 786-794.

3 Hockaday TD : Diabetic maculopathy. Br Med J 1983 ; 286 : 915-916.

4 Ivanisevic M : Diabetic maculopathy. liec Vjesn 1992 ; 114 : 300-303.

5 Diabetic Retinopathy Clinical Research Network : Diabetic maular edema : what is focal and what is diffuse? Am J Ophthalmol 2008 ; 146 : 649-655.

6 Early Treatment of Diabetic Retinopathy Study Research Group : Photocoagulation for diabetic macular edema. Arch Ophthalmol 1985 ; 103 : 1796-1806.

7 Wilkinson CP, et al : Proposed internation clinical diabetic retinopathy and diabetic macular edema. Disease severity scales. Ophthalmology 2003 ; 110 : 1677-1682.

8 Otani T, et al : Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999 ; 127 : 668-693.

i 大越貴志子 : 糖尿病黄斑浮腫へのレーザー光凝固術. 眼科 2011 ; 53 : 849-857.

P.103 掲載の参考文献

1 Bonini-Filho MA, et al : Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema : a randomized clinical trial. Invest Ophthalmol Vis Sci 2005 ; 46 : 3845-3849.

2 Ip MS, et al : Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004 ; 122 : 1131-1136.

3 Gillies MC, et al : Intravitreal triamcinolone for refractory diabetic macular edema. Two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006 ; 113 : 1533-1538.

4 Shimura M, et al : Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol 2009 ; 247 : 907-912.

5 Avitabile T, et al : Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005 ; 140 : 695-702.

6 Browning DJ, et al : Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema. Implications for sequence of application. Ophthalmology 2006 ; 113 : 1713-1719.

7 Rajendram R, et al : A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema ; 24-month data ; report 3. Arch Ophthalmol 2012 ; 130 : 972-979.

P.109 掲載の参考文献

1 Nguyen QD, et al : Ranibizumab for diabetic macular edema. Results from 2 phase III randomized trials : RISE and RIDE. Ophthalmology 2012 ; 119 : 789-801.

2 Mitchell P, et al : The RESTORE Study : Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011 ; 118 : 615-625.

3 Do DV, et al : The DA VINCI Study : phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Ophthalmology 2011 ; 118 : 1819-1826.

4 Nakano Goto S, et al : Treatment of diffuse diabetic macular oedema using steroid eye drops. Acta Ophthalmol 2012 ; 90 : 628-632.

5 Tanito M, et al : Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema. Invest Ophthalmol Vis Sci 2011 ; 52 : 7944-7948.

P.125 掲載の参考文献

1 Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985 ; 103 : 1796-1806.

2 Massin P, et al : Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study) : a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010 ; 33 : 2399-2405.

3 Nguyen QD, et al : Ranibizumab for diabetic macular edema : results from 2 phase III randomized trials : RISE and RIDE. Ophthalmology 2012 ; 119 : 789-801.

4 Nguyen QD, et al : Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. Ophthalmology 2009 ; 116 : 2175-2181.

5 Mitchell P, et al : The RESTORE study. Ophthalmology 2011 ; 118 : 615-625.

6 Elman MJ, et al : Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011 ; 118 : 609-614.

P.131 掲載の参考文献

1 Wake N, et al : Cost-effectiveness of intensive insulin therapy for type 2 diabetes : a 10-year follow-up of the Kumamoto study. Diabetes Res Clin Pract 2000 ; 48 : 201-210.

2 Ohkubo Y, et al : Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study. Diabetes Res Clin Pract 1995 ; 28 : 103-117.

3 Kawasaki R, et al : Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes : 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 2011 ; 54 : 2288-2294.

4 The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes 1986 ; 35 : 530-545.

5 森田千尋ら : 急激な血糖コントロールの網膜症に及ぼす影響-内科の立場より. Diabetes Journal 1992 ; 20 : 7-12.

6 Sone H, et al : Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 1996 ; 221 : 193-198.

7 福田全克ら : 内科医のための網膜症管理. 総合臨牀 1994 ; 43 : 2645-2649.

8 日本糖尿病学会編 : 増殖網膜症における血糖コントロール. 糖尿病専門医研修ガイドブック (改訂第4版). 2009. p.286-287.

2 角膜障害

P.136 掲載の参考文献

1 近間泰一郎ら : 加齢と涙液分泌 (シルマー試験) について. 日本眼科紀要 1995 ; 46 : 793-795.

2 内野佳代ら : 糖尿病患者における涙液分泌の減少. 日本眼科紀要 1995 ; 46 : 796-798.

3 Saito J, et al : Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy. Cornea 2003 ; 22 : 15-18.

4 Dogru M, et al : Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 2001 ; 108 : 586-592.

5 Chikama T, et al : Deviated mechanism of wound healing in diabetic corneas. Cornea 2007 ; 26 : S75-81.

P.139 掲載の参考文献

1 Inoue K, et al : Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea 2001 ; 20 : 798-801.

2 Saito J, et al : Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy. Cornea 2003 ; 22 : 15-18.

3 Dogru M, et al : Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 2001 ; 108 : 586-592.

4 Zao Z, et al : Advanced glycation end product (AGE) modified protein in tears of diabetic patients. Mol Vis 2010 ; 16 : 1576-1584.

5 Chang PY, et al : Decreased density of corneal besal epithelium and subbasal corneal nerve bundle changes in patients with diabetic retinopathy. Am J Ophthalmol 2006 ; 142 : 488-490.

6 Hossain P, et al : Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 2005 ; 366 : 1340-1343.

7 Kaji Y, et al : Advanced glycation end products in diabetic cornea. Invest Ophthalmol Vis Sci 2000 ; 23 : 362-368.

8 Gobbels M, et al : Impairment of corneal epithelial barrier function in diabetes. Graefe Arch Clin Exp Ophthalmol 1989 ; 227 : 142-144.

P.142 掲載の参考文献

1 細谷比左志 : 糖尿病性角膜症. あたらしい眼科 1996 ; 13 : 845-851.

2 細谷比左志 : 角膜障害の臨床像. シンポジウム II : 糖尿病と角膜障害. 日本眼科紀要 2002 ; 53 : 428-434.

3 細谷比左志 : 糖尿病角膜上皮症. 坪田一男編. 眼科プラクティス 3 オキュラーサーフェスのすべて. 東京 ; 文光堂 : 2005. p.251-257.

4 Azar DT, et al : Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol 1992 ; 110 : 537-540.

5 Azar DT, et al : Decreased penetration of anchoring fibrils into the diabetic cornea. A morphometric analysis. Arch Ophthalmol 1989 ; 107 : 1520-1523.

6 Kaji Y, et al : Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 2000 ; 41 : 362-368.

7 細谷比左志ら : 角膜表層穿刺の奏効した糖尿病性角膜症の3症例. 臨床眼科 1988 ; 42 : 13-16.

8 細谷比左志ら : 角膜表層穿刺 (anterior stromal puncture) の奏効した糖尿病角膜症の7症例. 日本眼科紀要 1991 ; 42 : 841-845.

9 Hosotani H, et al : Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. Am J Ophthalmol 1995 ; 119 : 288-294.

P.147 掲載の参考文献

1 Schultz RO, et al : Diabetic keratopathy. Trans Am Ophthalmol Soc 1981 ; 79 : 180-199.

2 細谷比左志 : 基本的な角膜上皮疾患の考え方と治療方法. 糖尿病角膜上皮症. あたらしい眼科 2006 ; 23 : 339-344.

3 西田輝夫 : 角膜その静と動. 日本眼科学会雑誌 2008 ; 112 : 179-213.

4 Chikama T, et al : Deviated mechanism of wound healing in diabetic corneas. Cornea 2007 ; 26 : S75-81.

5 Thoft RA, et al : The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci 1983 ; 24 : 1442-1443.

6 Kinoshita JH, et al : Aldose reductase in diabetic complications of the eye. Metabolism 1979 ; 28 : 462-469.

7 Kaji Y, et al : Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 2000 ; 41 : 362-368.

8 大橋裕一 : 糖尿病角膜症. 日本眼科学会雑誌 1997 ; 101 : 105-110.

9 Srinivasan S, et al : Corneal Manifestation of Metabolic Disease. In : Krachmer JH, et al, editors. Cornea, 3rd eds. Philadelphia : Mosby ; 2011. p.665-667.

10 Yamada M, et al : Decreased substance P concentrations in tears from patients with corneal hypesthesia. Am J Ophthalmol 2000 ; 129 : 671-672.

P.150 掲載の参考文献

1 井上幸次ら : 角膜・結膜に対する薬物障害. 眼科 1992 ; 34 : 1147-1154.

P.153 掲載の参考文献

1 Pardos GJ, et al : Comparison of endothelial cell density in diabetics and a control population. Am J Ophthalmol 1980 ; 90 : 172-174.

2 Schultz RO, et al : Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol 1984 ; 98 : 401-410.

3 Lee JS, et al : Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye 2006 ; 20 : 315-318.

4 Lass JH, et al : A morphologic and fluorophotometric analysis of the corneal endothelium in type I diabetes mellitus and cystic fibrosis. Am J Ophthalmol 1985 ; 100 : 783-788.

5 Keoleian GM, et al : Structural and functional studies of the corneal endothelium in diabetes mellitus. Am J Ophthalmol 1992 ; 113 : 64-70.

6 Herse PR : Corneal hydration control in normal and alloxan-induced diabetic rabbits. Invest Ophthalmol Vis Sci 1990 ; 31 : 2205-2213.

7 Lee JS, et al : Corneal endothelial cell change after phacoemulsification relative to the severity of diabetic retinopathy. Cataract Refractive Surgery 2005 ; 31 : 742-749.

8 Goebbels M, et al : Endothelial barrier function after phacoemulsification : a comparison between diabetic and non-diabetic patients. Graefes Arch Clin Exp Ophthalmol 1991 ; 229 : 254-257.

9 Morikubo S, et al : Corneal changes after small-incision cataract surgery in patients with diabetes mellitus. Arch Ophthalmol 2004 ; 122 : 966-969.

10 Ohguro N, et al : Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients. Br J Ophthalmol 1995 ; 79 : 1074-1077.

3 ぶどう膜炎

P.158 掲載の参考文献

1 北市伸義ら : 虹彩炎. 樋田哲夫編眼科プラクティス 7 糖尿病眼合併症の治療指針. 東京 : 文光堂 ; 2006. p.162-164.

2 Goto H, et al : Epidemiology servey of intraocular inflammation in Japan. Jpn J Ophthalmol 2007 ; 51 : 41-44.

3 南場研一ら : Behcet 病. 臨床眼科 2010 ; 64 : 630-636.

4 南場研一ら : HLA-B27関連ぶどう膜炎. 臨床眼科 2008 ; 62 : 1950-1954.

5 北市伸義 : 炎症性腸疾患に伴うぶどう膜炎. 園田康平編. 専門医のための眼科診療クオリファイ 13 ぶどう膜炎を斬る! . 東京 : 中山書店 ; 2012. p.238-241.

6 北市伸義ら : 糖尿病虹彩炎. 臨床眼科 2010 ; 64 : 2010-2013.

P.163 掲載の参考文献

1 藤関義人ら : 過去5年間の内因性細菌性眼内炎の検討. 臨床眼科 2002 ; 56 : 447-450.

2 秦野寛ら : 日本の眼内炎の現状-発症動機と起炎菌. 日本眼科学会雑誌 1991 ; 95 : 369-376.

3 有山泰代ら : 感染性眼内炎を併発したコントロール不良糖尿病の4例. 日本眼科紀要 2006 ; 57 : 726-729.

4 Bispo PJ, et al : Detection and gram discrimination of bacterial pathogens from aqueous and vitreous humor using real-time PCR assays. Invest Ophthalmol Vis Sci 2011 ; 52 : 873-881.

4 白内障

P.168 掲載の参考文献

1 Klein BE, et al : Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities : the Beaver Dam Eye Study. Am J Ophthalmol 1998 ; 126 : 782-790.

2 Leske MC, et al : Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology 1999 ; 106 : 35-41.

3 Oishi N, et al : Correlation between adult diabetic cataracts and red blood cell aldose reductase levels. Invest Ophthalmol Vis Sci 2006 ; 47 : 2061-2064.

4 Franke S, et al : Increased levels of advanced glycation end products in human cataractous lenses. J cataract refract surg 2003 ; 29 : 998-1004.

5 Chew EY, et al : Aspirin effects on the development of cataracts in patients with diabetes mellitus. Early treatment diabetic retinopathy study reports 16. Arch Ophthalmol 1992 ; 110 : 339-342.

6 Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group : A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for agerelated lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology 2008 ; 115 : 599-607.

P.176 掲載の参考文献

1 Hong T, et al : Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery. Ophthalmology 2009 ; 116 : 1510-1514.

2 Hayashi K, et al : Changes in diabetic macular oedema after phacoemulsification surgery. Eye 2009 ; 23 : 389-396.

3 Hayashi K, et al : Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. Am J Ophthalmol 2002 ; 134 : 10-16.

4 Suto C, et al : Effect of perioperative glycemic control in progression of diabetic retinopathy and maculopathy. Arch Ophthalmol 2006 ; 124 : 38-45.

P.186 掲載の参考文献

1 須藤史子 : 糖尿病と白内障手術-糖尿病を合併する白内障手術のコツと落とし穴. IOL & RS 2007 ; 21 : 155-161.

2 大島佑介 : 網膜硝子体疾患. あたらしい眼科 2006 ; 23 : 165-171.

3 渡辺朗ら : 光学部径7 mm眼内レンズの白内障・硝子体同時手術における有用性. あたらしい眼科 2009 ; 26 : 1413-1415.

4 麻生宏樹ら : 同一デザインのアクリルとシリコーン眼内レンズの固定状態の比較. 臨床眼科 2007 ; 61 : 237-242.

5 安藤展代ら : 後発白内障の発生に関与する多因子の検討. 臨床眼科 1999 ; 53 : 91-97.

6 松島博之ら : 前嚢収縮・後発白内障. 日本白内障学会誌 2011 ; 23 : 13-18.

7 小早川信一郎ら : 白色混濁を呈したハイドロジェル眼内レンズ. 眼科手術 2003 ; 16 : 419-426.

8 早田光孝ら : 眼内レンズの経年変化と視機能. IOL & RS 2008 ; 22 : 321-325.

9 吉岡由利子ら : シリコーン眼内レンズ挿入眼の硝子体手術時の問題点. 眼科手術 2005 ; 18 : 383-386.

10 Tanaka K, et al : Calcification and membrane formation on the surface of intraocular lenses in a rabbit model. Curr Eye Res 2012 ; 37 : 471-478.

5 血管新生緑内障

P.190 掲載の参考文献

1 大矢佳美ら : 血管新生緑内障に対する硝子体手術の評価としての蛍光前眼部造影. 日本眼科学会雑誌 2005 : 109 : 741-747.

P.194 掲載の参考文献

1 田原昭彦 : 血管新生緑内障の治療戦略. 臨床眼科 2009 ; 63 : 351-355.

2 Aiello LP : Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994 ; 331 : 1480-1487.

3 田原昭彦 : 緑内障と前房隅角. 第20回日本緑内障学会須田記念講演. あたらしい眼科 2010 ; 27 : 1067-1076.

4 Kubota T, et al : Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma. Br J Ophthalmol 1996 ; 80 : 750-754.

5 猪俣孟ら : 糖尿病と眼-形態学的にみた糖尿病眼合併症. 細胞 1993 ; 25 : 180-184.

6 Ishibashi S, et al : Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection. Arch Ophthalmol 2010 ; 128 : 1539-1545.

P.199 掲載の参考文献

1 Nomoto H, et al : Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits. Invest Ophthalmol Vis Sci 2009 ; 50 : 4807-4813.

2 Wakabayashi T, et al : Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008 ; 115 : 1571-1580.

P.203 掲載の参考文献

1 Aiello LP, et al : Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Eng J Med 1994 ; 331 : 1480-1487.

2 Tripanti RC, et al : Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998 ; 105 : 232-237.

3 Ehlers JP, et al : Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 2008 ; 28 : 696-702.

4 Saito Y, et al : Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol 2010 ; 88 : 96-102.

5 Takihara Y, et al : Combined intravitreal bevacizumab and trabeculectomy with mitimycin C versus trabeculectomy with mitimycin C alone for neovascular glaucoma. J Glaucoma 2011 ; 20 : 196-201.

6 Gedde SJ, et al : Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol 2009 ; 148 : 670-684.

6 視神経症

P.210 掲載の参考文献

1 Arnold AC : Ischemic optic neuropathy. In : Miller NR, et al, editors. Walsh & Hoyt's Clinical Neuro-Ophthalomoloy. 6th ed. Philadelphia : Lippincott Williams & Wilkins ; 2005. p.349-384.

2 Newman NJ, et al : The fellow eye in NAION : Report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002 ; 134 : 317-328.

3 Preechawat P, et al : Anterior ischemic optic neuropathy in patients younger than 50 years. Am J Ophthalmol 2007 ; 144 : 953-960.

4 Danesh-Meyer HV, et al : The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2001 ; 108 : 593-598.

5 Salomon O, et al : Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999 ; 106 : 739-742.

6 Hayreh SS, et al : Nonarteritic anterior ischemic optic neuropathy : clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology 2008 ; 115 : 1818-1825.

7 Lee AG, et al : Should steroids be offered to patients with nonarteritic ischemic optic neuropathy? J Neuroophthalmol 2010 ; 30 : 193-198.

8 中馬秀樹 : 非動脈炎性虚血性視神経症の治療トライアル. 中馬秀樹編. 専門医のための眼科診療クオリファイ 7 視神経疾患のすべて. 東京 : 中山書店 ; 2011. p.79-81.

9 Ostri C, et al : Bilateral diabetic papillopathy and metabolic control. Ophthalmology 2010 ; 117 : 2214-2217.

10 Nakamura M, et al : Serous macular detachment due to diabetic papillopathy detected with optical coherence tomography. Arch Ophthalmol 2009 ; 127 : 105-107.

11 中村誠 : 遺伝性視神経症. 眼科 2008 ; 50 : 1031-1037.

12 Gerbitz KD : Reflexions on a newly discovered diabetogenic gene, wolframin (WFS1). Diabetologia 1999 ; 42 : 627-630.

13 Amr S, et al : A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am J Hum Genet 2007 ; 81 : 673-683.

14 Petersen RA, et al : Optic nerve hypoplasia with good visual acuity and visual field defects : a study of children of diabetic mothers. Arch Ophthalmol 1977 ; 95 : 254-258.

15 Kim RY, et al : Superior segmental optic hypoplasia. A sign of maternal diabetes. Arch Ophthalmol 1989 ; 107 : 1312-1315.

16 Hashimoto M, et al : Topless optic disk without maternal diabetes. Am J Ophthalmol 1999 ; 128 : 111-112.

17 Barber AJ, et al : The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011 ; 52 : 1156-1163.

18 Kanamori A, et al : Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure. Curr Eye Res 2004 ; 28 : 47-54.

19 Tan GS, et al : Diabetes, metabolic abnormalities, and glaucoma. Arch Ophthalmol 2009 ; 127 : 1354-1361.

20 Mitchell P, et al : Open-angle glaucoma and diabetes : the Blue Mountain Eye Study, Australia. Ophthalmology 1997 ; 104 : 712-718.

21 De Voogd S, et al : Is diabetic mellitus a risk factor for open-angle glaucoma? The Rotterdam Study. Ophthalmology 2006 ; 113 : 1827-1831.

22 Pasquale LR, et al : Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology 2006 ; 113 : 1081-1086.

23 Fort PE, et al : Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death : Evidence for retinal insulin resistance. Plos One 2011 ; 6 : e26498.

24 Quigley HA : Can diabetes be good for glaucoma? Why can't we believe our own eyes (or data)? Arch Ophthalmol 2009 ; 127 : 227-229.

25 Dogru M, et al : Modifying factors related to asymmetric diabetic retinopathy. Eye 1998 ; 12 : 929-933.

P.218 掲載の参考文献

1 秋澤尉子 : 糖尿病網膜症患者の散瞳効果. 日本眼科学会雑誌 1987 ; 91 : 254-259.

2 磯谷治彦 : 糖代謝異常の進展と瞳孔反応. 日本眼科紀要 1998 ; 49 : 973-976.

3 Hayashi M, et al : Pharmacology of pupillary responses in diabetics. Jpn J Ophthalmol 1979 ; 23 : 65-72.

4 Ishikawa S, et al : Electoron-microscopic study of iris nerves and muscles in diabetes. Ophthalmologica 1985 ; 191 : 172-183.

5 Cahill M, et al : Pupillary autonomic denervation with increasing duration of diabetes mellitus. Br J Ophthalmol 2001 ; 85 : 1225-1230.

6 磯谷治彦ら : 境界型および糖尿病患者の瞳孔異常-暗順応時瞳孔面積, 対光反応および薬剤点眼試験による検討-. 自律神経 1994 ; 31 : 514-519.

7 難波健ら : 糖尿病における対光反応の分析 (第2報). 臨床眼科 1981 ; 35 : 440-443.

8 Apple DJ, et al : Ocular Pathology : Clinical applications and self-assessment. 5th ed. Missouri : Mosby ; 1998. p.380-382.

9 中里良彦ら : 瞳孔からみた糖尿病. 日本眼科紀要 1999 ; 50 : 91-96.

10 野村恒民ら : 糖尿病における血管新生緑内障前房隅角のfibrovascular membrane発現から虹彩炎表面の内皮新生に到るまでの進展様式に関する病理組織学的検討. 日本眼科学会雑誌 1982 ; 86 : 166-175.

11 Berson DM, et al : Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002 ; 295 : 1070-1073.

12 浅川賢ら : ヒト対光反応におけるメラノプシン含有網膜神経節細胞の関与. 自律神経 2009 ; 46 : 236-240.

13 Feigl B, et al : The post-illumination pupil response of melanopsin-expressing intrinsically photosensitive retinal ganglion cells in diabetes. Acta Ophthalmol 2012 ; 90 : e230-234.

14 Rogell GD : Internal ophthalmoplegia after argon laser panretinal photocoagulation. Arch Ophthalmol 1979 ; 97 : 904-905.

15 内海隆 : 糖尿病と瞳孔. 神経眼科 1998 ; 15 : 148-154.

7 眼科・内科連携

P.224 掲載の参考文献

1 船津英陽ら : 糖尿病眼手帳, 眼手帳作成の背景, 経緯, 内容, 使用法について. 日本の眼科 2003 ; 74 : 345-348.

2 堀貞夫 : 糖尿病網膜症の治療戦略. 日本眼科学会雑誌 2010 ; 114 : 202-216.

3 Fanatsu H, et al : Present status of ophthalmological care for diabetic patients in Japan. Jpn J Ophtalmol 2000 ; 44 : 75-81.

4 Funatsu H, et al : Questionnaire survey on periodic ocular examination in Japanese diabetic patient. Am J Ophthalmol 2003 ; 136 : 955-957.

5 船津英陽 : 眼科管理の問題点と糖尿病と糖尿病眼手帳. 糖尿病診療マスター 2003 ; 1 : 383-385.

6 船津英陽 : 糖尿病網膜症の医療連携放置中断をなくすために眼科受診中断の問題点とその対策. 日本眼科紀要 2002 ; 53 : 7-11.

7 船津英陽ら : 眼科医・内科医・コメディカルの連携を目指して糖尿病眼手帳. 日本眼科紀要 2005 ; 56 : 242-246.

8 船津英陽ら : 糖尿病眼手帳の5年間の推移. 日本眼科学会雑誌 2010 ; 114 : 96-104.

9 善本三和子ら : 糖尿病眼手帳についてのアンケート調査. 日本眼科紀要 2004 ; 55 : 275-280.

10 大野敦ら : 多摩地域の眼科医における糖尿病眼手帳に対するアンケート調査結果の推移. あたらしい眼科 2011 ; 28 : 97-102.

P.228 掲載の参考文献

1 Kawasaki R, et al : Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes : 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 2011 ; 54 : 2288-2294.

2 Chung N, et al : Diabetic retinopathy. The Lancet 2010 ; 376 : 124-136.

3 Ohkubo Y, et al : Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study. Diabetes Res Clin Pract 1995 ; 28 : 103-117.

4 The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 ; 329 : 977-986.

5 The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000 ; 342 : 381-389.

6 UK Prospective Diabetes Study (UKPDS) Group : Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 ; 352 : 837-853.

7 The ACCORD Study Group and ACCORD Eye Study Group : Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes. N Engl J Med 2010 ; 363 : 233-244.

8 Mohamed Q, et al : Management of diabetic retinopathy. A systemic review. JAMA 2008 ; 298 : 902-916.

9 UK Prospective Diabetes Study Group : Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes : UKPDS 38. BMJ 1998 ; 317 : 703.

10 Matthews DR, et al : Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus : UKPDS 69. Arch Ophthalmol 2004 ; 122 : 1631-1640.

11 Holman RR, et al : Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008 ; 359 : 1565-1576.

12 Chaturvedi N, et al : Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. Lancet 1998 ; 351 : 28-31.

13 ADVANCE Collaborative Group : Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial) : a randomised controlled trial. Lancet 2007 ; 370 : 829-840.

14 Sjolie AK, et al : Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial. Lancet 2008 ; 372 : 1385-1393.

15 Chaturvedi N, et al : Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes : randomised, placebo-controlled trials. Lancet 2008 ; 372 : 1394-1402.

16 Mauer M, et al : Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009 ; 361 : 40-51.

17 Lyons TJ, et al : Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 2004 ; 45 : 910-918.

18 Keech AC, et al : Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study) : a randomised controlled trial. Lancet 2007 ; 370 : 1687-1697.

19 Gaede P, et al : Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008 ; 358 : 580-591.

P.232 掲載の参考文献

1 Klein R, et al : The Wisconsin Epidemiologic Study of Diabetic Retinopathy : XVII. The 14-year incidence and progression of diabetic retionopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998 ; 105 : 1799-1800.

2 Diabetes Control and Complications Trail Research Group : The effect of intensive treatment of diabetes on the development and progression of long-trem complications in insulindependent diabetes mellitus. N Engl J Med 1993 ; 329 : 977-986.

3 UK Prospective Diabetes Group : Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS34). Lancet 1998 ; 352 : 854-865.

4 Perkovich BT, et al : Systemic factors affecting diabetic macular edema. Am J Ophthalmol 1988 ; 105 : 211-212.

5 Early Treatment Diabetic Retinopathy Study Research Group. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy. Arch Ophthlmol 1996 ; 114 : 1079-1084.

6 Keech A, et al : Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study) : a randomized controlled trial. Lancet 2007 ; 370 : 1687-1697.

7 ACCORD Study Group : ACCORD Eye Study Group, et al. Effect of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010 ; 363 : 233-244.

8 ロービジョンケア

P.238 掲載の参考文献

1 佐藤里奈ら : わが国における視覚障害の原因. 網膜脈絡膜・視神経萎縮症に関する調査研究平成23年度総括・分担研究報告書 2012 ; 65-66.

2 Mazhar K, et al : Los Angeles Latino Eye Study Group.Severity of diabetic retinopathy and health-related quality of life : the Los Angeles Latino Eye Study. Ophthalmology 2011 ; 118 : 649-655.

3 Anderson RJ, et al : The prevalence of comorbid depression in adults with diabetes : a metaanalysis. Diabetes Care 2001 ; 24 : 1069-1078.

4 Warrian KJ, et al : The assessment of disability related to vision performance-based measure in diabetic retinopathy. Am J Ophthalmol 2010 ; 149 : 852-860.

5 Brody BL, et al : Age-related macular degeneration : Self-management and reduction of depressive symptoms in a randomized, controlled study. J Am Geriatr Soc 2006 ; 54 : 1557-1562.

6 東めぐみ : 外来看護相談におけるコミュニケーション. 看護実践の科学 2012 ; 37 : 43-60.

7 田中恵津子 : 糖尿病網膜症患者を対象としたロービジョンケアの特性. 日本眼科紀要 2006 ; 57 : 498-505.

書評

書評を投稿する

最近チェックした商品履歴

Loading...